ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Advanced Radiation Technique Reduced Swallowing Problems

May 28, 2010

RFA Available

January 15, 1999

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986